DNLI Competitors & Alternatives
Compare Denali Therapeutics Inc with similar stocks in the same industry
Biotechnology
DNLI
Main Stock$23.02
Tradestie Score
55
Market Cap
$2.18B
Revenue Growth
-1.0%
Analyst Upside
+49.1%
Top Competitors
230 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
PTGX
Protagonist Therapeutics, Inc
|
$136.64
|
$3.98B | - | 56 | Compare |
|
CRNX
Crinetics Pharmaceuticals, Inc.
|
$83.52
|
$3.92B | - | 47 | Compare |
|
KYMR
Kymera Therapeutics, Inc. Common Stock
|
$103.40
|
$3.91B | - | 59 | Compare |
|
ZLAB
Zai Lab Limited American Depositary Shares
|
$18.27
|
$3.83B | - | 47 | Compare |
|
AAPG
Ascentage Pharma Group International American Depository Shares
|
$17.43
|
$3.68B | - | 45 | Compare |
|
MIRM
Mirum Pharmaceuticals, Inc. Common Stock
|
$105.95
|
$3.67B | - | 59 | Compare |
|
ADMA
ADMA Biologics, Inc.
|
$8.46
|
$3.59B | 12.8 | 48 | Compare |
|
ACAD
Acadia Pharmaceuticals Inc.
|
$25.87
|
$3.58B | 11.9 | 58 | Compare |
|
LGND
Ligand Pharmaceuticals Inc.
|
$287.54
|
$3.49B | 37.6 | 57 | Compare |
|
TLX
Telix Pharmaceuticals Limited American Depositary Shares
|
$9.89
|
$3.40B | - | 46 | Compare |
More DNLI Analysis
Data updated: Aug 02, 2026 | Industry: Biotechnology (SIC 2836)
230 stocks in this industry